ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 244

Hospitalization and Flare Risk in Patients with Established Gout: A Population-Based Study

Nour Zleik1, Mohanad Elfishawi1, Zoran Kvrgic1, Clement J. Michet Jr.2, Cynthia S. Crowson3, Eric L. Matteson4 and Tim Bongartz1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity and gout

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hospitalization of patients with gout may be associated with an increased risk of arthritic flares, due to administration of IV fluids, discontinuation of established uric acid lowering therapies and other medication changes. While previous studies have suggested an association of gouty arthritis and hospitalization, the absolute flare risk has not been identified. We aimed to determine the risk of flares with future hospitalizations and examine potential predictors of in-hospital gout flares.

Methods: We examined a population-based incidence cohort of patients with gout, diagnosed according to the New York, Rome or ACR preliminary criteria during two time periods:  1989 – 1992 and 2009 – 2010. All subjects were followed longitudinally through their complete medical records, until 5 years after their first gout attack, death or migration, whichever came first. Hospitalizations of each subject were recorded and hospital records were evaluated for a possible flare of gouty arthritis. Person-year methods were used to calculate the rate of flares of gouty arthritis during hospitalizations and out-of-hospital. In addition, mixed logistic regression models with random subject effects (accounting for multiple hospitalizations per subject) were used to explore risk factors of in-hospital gout flares.

Results:

429 patients with incident gout were followed for a mean of 4.2 years. The majority of patients were male (73%) and the mean age (SD) at gout onset was 59.7 (17.3).  169 patients had at least 1 hospitalization (cumulative incidence of first hospitalization was 39.1% for patients diagnosed in 1989-1992 compared to 43.1% for patients diagnosed in 2009-2010; p=0.56), with a total of 454 hospitalizations during the entire follow-up period. The rate of hospitalizations increased marginally from 2.26 per 10 person-years (py) in 1989-1992 to 3.49 per 10 py in 2009-2010 (rate ratio [RR]: 1.19; 95% confidence interval [CI]: 0.98, 1.45).

28 hospitalizations were complicated by a flare of gouty arthritis during a total of 3276 hospital days (9.0 total py) compared to 554 out-of hospital flares during 1784 py of follow-up. The rate of in-hospital flares was 85 per 100 py compared to 8.5 per 100 py out-of-hospital. Hospitalization was associated with a significantly increased risk of gout flares (RR: 10.2; 95% CI: 6.8, 14.5). In addition, the rate of in-hospital flares increased marginally over time (6.3 per 10 py in 1989-1992 vs 11.7 per 10 py in 2009-2010; RR: 1.85; 95% CI: 0.89, 4.00).

Various possible predictors of gout flares during hospitalization were evaluated, including discontinuation of established uric acid lowering therapy, administration of IV fluids, ICU admission, use of diuretics and reason for admission, but none were identified as statistically significant predictors of in-hospital flares.

Conclusion:

Hospitalization represents a significant risk factor for flares of gouty arthritis in patients with a prior diagnosis of gout, although the absolute risk is still low. Future studies are needed to clarify which patient subgroups are at particular risk and if inpatient care related measures can help to prevent arthritic flares during hospitalization.


Disclosure: N. Zleik, None; M. Elfishawi, None; Z. Kvrgic, None; C. J. Michet Jr., None; C. S. Crowson, None; E. L. Matteson, None; T. Bongartz, None.

To cite this abstract in AMA style:

Zleik N, Elfishawi M, Kvrgic Z, Michet CJ Jr., Crowson CS, Matteson EL, Bongartz T. Hospitalization and Flare Risk in Patients with Established Gout: A Population-Based Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/hospitalization-and-flare-risk-in-patients-with-established-gout-a-population-based-study-2/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hospitalization-and-flare-risk-in-patients-with-established-gout-a-population-based-study-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology